1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global Erectile Dysfunction Market 2016-2020

Global Erectile Dysfunction Market 2016-2020

  • September 2016
  • -
  • Infiniti Research Limited
  • -
  • 70 pages

About Erectile Dysfunction

The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels. The condition can be treated with a broad range of drugs and implants available in the market.

Technavio’s analysts forecast the global erectile dysfunction treatment market to witness a slow grow in market size of USD 4.08 billion during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global erectile dysfunction treatment market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of different types of penile implants, ED creams, and drugs, including branded and generic drugs.


The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, Global Erectile Dysfunction Treatment Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
- Bayer
- Boston Scientific
- Coloplast
- Eli Lilly
- Pfizer


Other prominent vendors
- Apricus Biosciences
- Cristalia Produtos Quimicos Farmaceuticos
- Dong-A Socio
- Endo Pharmaceuticals
- Futura Medical
- Meda Pharmaceuticals
- Promedon
- SK Chemical
- Teva Pharmaceuticals
- Vivus
- Zephyr Surgical Implants (ZSI)

Market driver
- Demand from older adult male population
- For a full, detailed list, view our report

Market challenge
- Threat of counterfeit products
- For a full, detailed list, view our report

Market trend
- Migration of manufacturing and sales facilities to APAC
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Table Of Contents

Global Erectile Dysfunction Market 2016-2020
PART 01: Executive summary
- Highlights
PART 02: Scope of the report
- Market overview
- Definition
- Vendor segmentation
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
- Key market highlights
PART 05: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 06: Market segmentation by product
- Global ED treatment market by product
- Global ED drugs market
- Global ED devices market
PART 07: Market segmentation by type of ED drugs
- Global ED treatment market by type of ED drugs
PART 08: Market segmentation by type of ED device
- Global ED treatment market by type of ED device
PART 09: Geographical segmentation
- Global ED treatment market by geography
- ED treatment market in Americas
- ED treatment market in EMEA
- ED treatment market in APAC
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
- Competitive scenario
PART 16: Key vendor analysis
- Bayer
- Boston Scientific
- Coloplast
- Eli Lilly
- Pfizer
- Other prominent vendors
PART 17: Appendix
- List of abbreviations
PART 18: Explore Technavio

List of Exhibits
Exhibit 01: Global erectile dysfunction treatment market by product
Exhibit 02: Key countries
Exhibit 03: Product offerings
Exhibit 04: Major causes of ED
Exhibit 05: Global ED treatment market 2015-2020 ($ billions)
Exhibit 06: Key drug patent expirations in major countries
Exhibit 07: Five forces analysis
Exhibit 08: Global ED treatment market by product 2015 and 2020
Exhibit 09: Global ED treatment market by product 2015-2020
Exhibit 10: Global ED drugs market 2015-2020 ($ billions)
Exhibit 11: Global ED devices market 2015-2020 ($ millions)
Exhibit 12: ED device market by geography 2015 and 2020
Exhibit 13: Global ED treatment market by type of ED drugs 2015
Exhibit 14: Global ED treatment market by type of ED device 2015 and 2020
Exhibit 15: Global ED treatment market by geography 2015 and 2020
Exhibit 16: Global ED treatment market by geography 2015-2020 ($ millions)
Exhibit 17: ED treatment market in Americas 2015-2020 ($ billions)
Exhibit 18: ED treatment market in Americas by drugs and devices
Exhibit 19: ED treatment market in EMEA 2015-2020 ($ billions)
Exhibit 20: Occurrence of ED by age 2015
Exhibit 21: ED treatment market in EMEA by drugs and devices 2015 and 2020
Exhibit 22: ED treatment market in APAC 2015-2020 ($ millions)
Exhibit 23: ED treatment market in APAC by drugs and devices 2015 and 2020
Exhibit 24: ED treatment Market by product across regions 2015 and 2020 ($ million)
Exhibit 25: Estimated cancer cases and deaths in US 2016 (thousands)
Exhibit 26: Chances of men developing ED by age in the US
Exhibit 27: Number of individuals with diabetes around the world 2015 and 2040 (millions)
Exhibit 28: Impact of drivers
Exhibit 29: Impact of drivers and challenges
Exhibit 30: Bayer: Key takeaways
Exhibit 31: Boston Scientific: Key takeaways
Exhibit 32: Coloplast: Key takeaways
Exhibit 33: Eli Lilly: Key takeaways
Exhibit 34: Pfizer: Key takeaways

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.